| Dr Sandra L Sicilia, MD | |
|
4815 N Assembly St, Spokane, WA 99205-6185 | |
| (509) 434-7000 | |
| Not Available |
| Full Name | Dr Sandra L Sicilia |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 4815 N Assembly St, Spokane, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720176738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | M-8225 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sandra L Sicilia, MD 19215 N Sands Rd, Colbert, WA 99005-8526 Ph: (509) 238-9162 | Dr Sandra L Sicilia, MD 4815 N Assembly St, Spokane, WA 99205-6185 Ph: (509) 434-7000 |
News Archive
Telephone counseling might be an effective primary care intervention for men who are not seeking treatment for their alcohol dependence or abuse, according to a new study.
Sedentary behaviour is not a clearcut risk factor for prostate cancer, analysis of a large population-based cohort indicates.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced treatment of the first patient in a Phase 1 clinical trial of LV305, an immuno-oncology investigational agent from the company's DCVexTM lentiviral vector platform.
Ships are inadvertently carrying trillions of stowaways in the water held in their ballast tanks. When the water is pumped out, invasive species could be released into new environments. Disease-causing microbes could also be released, posing a risk to public health, according to an article in the May issue of Microbiology Today.
› Verified 3 days ago
Dr. Richard W Walker, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5633 N Lidgerwood St, Spokane, WA 99208 Phone: 509-484-8069 Fax: 509-462-4086 | |
Lynn Bergman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5633 N Lidgerwood, Emergency Physicians Services, Spokane, WA 99208 Phone: 509-482-2448 Fax: 509-482-2452 | |
Mary Anna Chiu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5633 N Lidgerwood St, Spokane, WA 99208 Phone: 509-482-2448 Fax: 509-482-2452 | |
David S Mcclellan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 | |
Charles N. Roberts, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5633 N. Lidergerwood, Spokane, WA 99208 Phone: 509-482-0111 | |
Stephen Penaskovic, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 | |
Michael J Wymore, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 |